PDF(Sci-hub)
Abstract：
UNASSIGNED: Despite their adverse effects, antipsychotics are frequently used to manage behavioral and psychological symptoms of dementia. Regular monitoring of antipsychotic prescribing has been shown to improve the appropriateness of prescribing. However, there is currently no consensus on what the components of such a monitoring tool would be.
UNASSIGNED: The aim of this study was to use an expert consensus process to identify the key components of an antipsychotic repeat prescribing tool for use with people with dementia in a general practice setting.
UNASSIGNED: A modified eDelphi technique was employed. We invited multidisciplinary experts in antipsychotic prescribing to people with dementia to participate. These experts included general practitioners (GPs), geriatricians and old age psychiatrists. The list of statements for round 1 was developed through a review of existing monitoring tools and international best practice guidelines. In the second round of the Delphi, any statement that had not reached consensus in the first round was presented for re-rating, with personalized feedback on the group and the individual\'s response to the specific statement. The final round consisted of a face-to-face expert meeting to resolve any uncertainties from round 2.
UNASSIGNED: A total of 23 items were rated over two eDelphi rounds and one face-to-face consensus meeting to yield a total of 18 endorsed items and five rejected items. The endorsed statements informed the development of a structured, repeat prescribing tool for monitoring antipsychotics in people with dementia in primary care.
UNASSIGNED: The development of repeat prescribing tool provides GPs with practical advice that is lacking in current guidelines and will help to support GPs by providing a structured format to use when reviewing antipsychotic prescriptions for people with dementia, ultimately improving patient care. The feasibility and acceptability of the tool now need to be evaluated in clinical practice.
UNASSIGNED: The aim of this study was to use an expert consensus process to identify the key components of an antipsychotic repeat prescribing tool for use with people with dementia in a general practice setting.
UNASSIGNED: A modified eDelphi technique was employed. We invited multidisciplinary experts in antipsychotic prescribing to people with dementia to participate. These experts included general practitioners (GPs), geriatricians and old age psychiatrists. The list of statements for round 1 was developed through a review of existing monitoring tools and international best practice guidelines. In the second round of the Delphi, any statement that had not reached consensus in the first round was presented for re-rating, with personalized feedback on the group and the individual\'s response to the specific statement. The final round consisted of a face-to-face expert meeting to resolve any uncertainties from round 2.
UNASSIGNED: A total of 23 items were rated over two eDelphi rounds and one face-to-face consensus meeting to yield a total of 18 endorsed items and five rejected items. The endorsed statements informed the development of a structured, repeat prescribing tool for monitoring antipsychotics in people with dementia in primary care.
UNASSIGNED: The development of repeat prescribing tool provides GPs with practical advice that is lacking in current guidelines and will help to support GPs by providing a structured format to use when reviewing antipsychotic prescriptions for people with dementia, ultimately improving patient care. The feasibility and acceptability of the tool now need to be evaluated in clinical practice.
摘要：
■尽管有不利影响，抗精神病药物经常用于治疗痴呆的行为和心理症状。定期监测抗精神病药处方已被证明可以提高处方的适当性。然而,目前还没有就这种监测工具的组成部分达成共识。
这项研究的目的是使用专家共识程序来确定抗精神病药重复处方工具的关键组成部分，该工具适用于一般实践中的痴呆症患者。
■采用了改进的eDelphi技术。我们邀请了痴呆症患者抗精神病药处方的多学科专家参加。这些专家包括全科医生(GP)，老年医生和老年精神病医生。第一轮的发言清单是通过审查现有监测工具和国际最佳做法准则制定的。在德尔福的第二轮中，任何在第一轮中未达成共识的声明都被提交重新评级，对小组和个人的具体陈述的回应进行个性化反馈。最后一轮由面对面的专家会议组成，以解决第二轮的任何不确定性。
■在两次eDelphi回合和一次面对面共识会议上，总共对23个项目进行了评级，总共产生了18个认可项目和5个拒绝项目。认可的声明告知了一个结构化的发展，在初级保健中监测痴呆症患者抗精神病药物的重复处方工具。
■重复处方工具的开发为全科医生提供了当前指南中缺乏的实用建议，并将通过提供结构化格式来支持全科医生，以在审查痴呆症患者的抗精神病药物处方时使用。最终改善患者护理。现在需要在临床实践中评估该工具的可行性和可接受性。
这项研究的目的是使用专家共识程序来确定抗精神病药重复处方工具的关键组成部分，该工具适用于一般实践中的痴呆症患者。
■采用了改进的eDelphi技术。我们邀请了痴呆症患者抗精神病药处方的多学科专家参加。这些专家包括全科医生(GP)，老年医生和老年精神病医生。第一轮的发言清单是通过审查现有监测工具和国际最佳做法准则制定的。在德尔福的第二轮中，任何在第一轮中未达成共识的声明都被提交重新评级，对小组和个人的具体陈述的回应进行个性化反馈。最后一轮由面对面的专家会议组成，以解决第二轮的任何不确定性。
■在两次eDelphi回合和一次面对面共识会议上，总共对23个项目进行了评级，总共产生了18个认可项目和5个拒绝项目。认可的声明告知了一个结构化的发展，在初级保健中监测痴呆症患者抗精神病药物的重复处方工具。
■重复处方工具的开发为全科医生提供了当前指南中缺乏的实用建议，并将通过提供结构化格式来支持全科医生，以在审查痴呆症患者的抗精神病药物处方时使用。最终改善患者护理。现在需要在临床实践中评估该工具的可行性和可接受性。
